Atlas Trials

Combined Hepatocellular and Cholangiocarcinoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Combined Hepatocellular and Cholangiocarcinoma

RecordFirmDate
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma (NCT06855225)Mehmet Akce2026-07-01
Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data (NCT06849180)Zhongda Hospital2024-12-31
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (NCT03230318)Basilea Pharmaceutica2017-09-28

Track Combined Hepatocellular and Cholangiocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.